| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| CD146 targeting CAR-T cell therapy (Essen Biotech) | Phase 2 Clinical | Essen Biotech | Carcinoma, Ovarian Epithelial; Osteosarcoma; Ovarian Neoplasms; Sarcoma; Sarcoma, Ewing; Sarcoma, Kaposi; Sarcoma, Synovial | Details | |
| AMT-253(Multitude) | AMT-253; AMT-253 ADC | Phase 2 Clinical | Multitude Therapeutics Inc | Melanoma; Solid tumours | Details |